Stay updated with breaking news from Stealth Editors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New preclinical data validates that Stealth Editors™ are non-immunogenic, as featured in a poster presentation at the 28th American Peptide Symposium First non-human primate (NHP) study to successfully redose a gene editor without an immune r...
PITTSBURGH, June 28, 2023 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology company developing Stealth Editors™ to perform in vivo gene editing without
16.05.2023 - Appointed Jeffrey Kindler, J.D. and John Maraganore, Ph.D. as strategy and business advisors to the CompanyPITTSBURGH, May 16, 2023 (GLOBE NEWSWIRE) - NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology company ... Seite 1